Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

81.23
+2.813.58%
Post-market: 81.500.2700+0.33%19:45 EST
Volume:2.25M
Turnover:181.36M
Market Cap:9.55B
PE:17.15
High:81.36
Open:79.01
Low:78.76
Close:78.42
52wk High:81.36
52wk Low:47.50
Shares:117.60M
Float Shares:116.00M
Volume Ratio:0.87
T/O Rate:1.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.74
EPS(LYR):3.43
ROE:124.50%
ROA:21.24%
PB:18.96
PE(LYR):23.68

Loading ...

Halozyme Therapeutics CEO Helen Torley Reports Disposal of Common Shares

Reuters
·
Yesterday

Is Halozyme Therapeutics (HALO) Still Attractive After Recent Drug Delivery Partnership-Driven Gains

Simply Wall St.
·
Feb 01

Morgan Stanley Lifts Price Target on Halozyme Therapeutics to $78 From $75, Keeps Overweight Rating

MT Newswires Live
·
Jan 29

Halozyme Therapeutics Raises 2025, 2026 Outlooks

MT Newswires Live
·
Jan 28

GUIDANCE: (HALO) Halozyme Therapeutics Expects Full Year 2026 Non-GAAP EPS Range $7.75 - $8.25, vs. FactSet Est of $8.24

MT Newswires Live
·
Jan 28

GUIDANCE: (HALO) Halozyme Expects Full Year 2026 Revenue Range of $1.71B - $1.81B, vs. FactSet Est of $1.69B

MT Newswires Live
·
Jan 28

Halozyme Therapeutics Outlook FY Revenue USD 1,385-1,400 Million

THOMSON REUTERS
·
Jan 28

Halozyme Therapeutics Inc FY2026 Shr View $8.19, REV View $1.69 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
Jan 28

Halozyme Therapeutics Inc Outlook 2026 Non-Gaap Diluted EPS to $7.75 - $8.25

THOMSON REUTERS
·
Jan 28

Halozyme - by 2026 End, We Project to Have 15 Partner Programs in Development; Have Signed Three or More New Drug Delivery Licensing Agreements

THOMSON REUTERS
·
Jan 28

Press Release: Halozyme Raises 2025 Revenue Estimates, Raises 2026 and Multi-Year Financial Guidance

Dow Jones
·
Jan 28

Cleantek Wins Major International Contract for HALO SE Industrial Lighting Systems

TIPRANKS
·
Jan 23

Halozyme Therapeutics Inc. to Provide Updated Financial Guidance and Business Update

Reuters
·
Jan 21

Is Takeda ENHANZE Deal on Vedolizumab Reshaping the Investment Case for Halozyme Therapeutics (HALO)?

Simply Wall St.
·
Jan 20

Analysts Offer Insights on Healthcare Companies: Climb Bio (CLYM) and Halozyme (HALO)

TIPRANKS
·
Jan 09

Leerink views ‘major deal’ on Entyvio as positive for Halozyme

TIPRANKS
·
Jan 09

Halozyme Therapeutics Is Maintained at Buy by TD Cowen

Dow Jones
·
Jan 09

BRIEF-Halozyme Announces Global Collaboration And License Agreement With Takeda

Reuters
·
Jan 08

Halozyme announces global collaboration, license agreement with Takeda

TIPRANKS
·
Jan 08

Halozyme and Takeda Announce Global Collaboration to Develop Vedolizumab with ENHANZE Technology

Reuters
·
Jan 08